Top Markets
Coin of the day
Psyence Group Inc. Psyence Group Inc.

Psyence Group Inc.

PSYG
Clasificación en acciones #38237
Psyence Group Inc. is a life sciences biotechnology company primarily engaged... Psyence Group Inc. is a life sciences biotechnology company primarily engaged in the commercial cultivation and production of psilocybin mushrooms. This naturally sourced psilocybin is intended for therapeutic applications, addressing a broad spectrum of mental health conditions and other medical ailments. The company is actively formulating pharmaceutical-grade psilocybin treatments designed to mitigate psychological trauma and recognized disorders such as anxiety, depression, post-traumatic stress disorder (PTSD), and the emotional distress linked to grief and bereavement. Furthermore, Psyence Group develops, distributes, and sells over-the-counter functional mushroom nutraceuticals, entirely free of psilocybin, under its GOODMIND brand. Established in 2019, the company maintains its headquarters in Toronto, Canada.
Precio por acción
$0.08765138
Última sincronización: 2025-12-23
Capitalización bursátil
$1.11M
Cambio (1 día)
0.45%
Cambio (1 año)
-28.78%
País
CA
Comercio Psyence Group Inc. (PSYG)

Categoría

Historial de rendimiento por dividendo de Psyence Group Inc. (PSYG)
Rendimiento por dividendo (TTM) de Psyence Group Inc. (símbolo bursátil: PSYG) al 2026: 0
Rendimiento promedio por dividendo de los últimos 5 años: 0.00%
Historial de rendimiento por dividendo de Psyence Group Inc. (PSYG) desde 2026 hasta 2026
Rendimiento por dividendo al final de cada año (TTM)
Año Rendimiento por dividendo Cambiar
Not enough data for the provided dates.
Rendimientos por dividendo (TTM) de empresas similares o competidoras
Empresa Rendimiento por dividendo País
0.56%
US
2.04%
US
2.72%
US
2.69%
CH
2.58%
US